The two new facilities will create 300 jobs and are part of the drugmaker’s broader plan to invest $100 billion in the U.S.

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

Biopharmaceutical company AbbVie plans to spend $380 million building two new manufacturing facilities in North Chicago, ...

North Chicago officials, in a statement, said the 11,365-square-foot center will include a convenience store, video gaming ...

AbbVie will build two new active pharmaceutical ingredient manufacturing facilities at its North Chicago headquarters over the next three years, investing $380 million and creating 300 new full-time ...